ome companies have a quick start. Others take a head-bangingly long time to develop their technology and begin to scale up. Christophe Schilling, who co-founded which makes bio-based alternatives to key chemicals, more than two decades ago, knows the long game of entrepreneurship well.Today, however, Schilling is flying high as he tells that his San Diego-based firm raised $118 million led by Novo Holdings, bringing Genomatica’s total funding to $388 million.
“It’s an interesting moment in time for us,” he says. “We have focused on these big-volume things because the ethos of the company is around sustainability. We think about volume and scale.” “It’s not just about some cool, sexy science that we’ve got to get right and it’s not only that we have to produce product—but the cost point that we’ve got to get to is quite low.”
Finance Finance Latest News, Finance Finance Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
See the pitch deck that clinical-trial firm Castor used to raise $45MThis entrepreneur thinks computer simulations could replace human drug-trial participants by 2035. See the pitch deck that helped his startup raise $45 million.
Source: BusinessInsider - 🏆 729. / 51 Read more »
Source: MSNBC - 🏆 469. / 51 Read more »